Sponsors (12)
The bill aims to reduce dependence on foreign agricultural inputs and strengthen supply‑chain resilience through interagency analysis and recommendations, but it risks higher costs for producers and consumers and greater regulatory/compliance burdens, potentially compounded by incomplete voluntary data.
Consumers, farmers, and small food businesses face a lower risk of shortages and price spikes because the bill directs analysis and recommendations to strengthen agricultural supply‑chain resilience and reduce reliance on Chinese inputs (fertilizers, seed, veterinary drugs).
Farmers and agricultural manufacturers receive clearer interagency guidance and actionable recommendations to diversify or onshore critical inputs, helping them plan investments and reduce foreign-dependence risks.
State and local policymakers (and other government actors) gain interagency-informed analysis they can use to design targeted legislative or regulatory fixes for agricultural vulnerabilities.
Farmers, small agricultural firms, and consumers may face higher costs because pressure to onshore production and implement recommended changes can raise production expenses that get passed along in prices.
Implementing recommended legislative or regulatory changes could increase government intervention in agricultural supply chains and impose new compliance costs on producers.
Private agricultural firms may be reluctant to share voluntary data, which could limit the completeness of assessments and lead to policy choices based on incomplete information.
Based on analysis of 2 sections of legislative text.
Introduced March 10, 2025 by John Peter Ricketts · Last progress March 10, 2025
Requires the Department of Agriculture to prepare and deliver an annual report to congressional agriculture committees analyzing U.S. reliance on agricultural products and inputs that could be disrupted if the People’s Republic of China weaponizes those dependencies. Each report must evaluate domestic production capacity and supply‑chain risks for listed critical inputs, and include recommendations—developed with Trade, Commerce, and FDA officials—on steps to reduce dependence, including mitigation measures and options to spur onshore or nearshore production. The law forbids compelling private entities to provide information and limits how submitted information may be used and disclosed.